slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,539
Current window 93,091-93,120
Pages 3,685
Rows per page 30
Component
93,091-93,120 of 110,539
17
The slide presents a data table on the left and supporting bullet points on the right.Flushing Financial | Results Presentation Deck | 40 slides · Flushing Financial Corporation
Conference presentation Investor relations Beat · FinancialsLoop · Before After1 hit
18
Uses a 'Before/After' style framing to contrast the bank's actual portfolio against the market's perception of 'Office CRE' risk.Flushing Financial | Results Presentation Deck | 40 slides · Flushing Financial Corporation
Conference presentation Investor relations Beat · FinancialsLoop · Before After1 hit
19
The chart highlights FFIC's position relative to peers; note that 'Peer 4' is listed twice on the x-axis.Flushing Financial | Results Presentation Deck | 40 slides · Flushing Financial Corporation
Conference presentation Investor relations Beat · FinancialsLoop · Before After1 hit
20
Uses a visual contrast to define lending strategy.Flushing Financial | Results Presentation Deck | 40 slides · Flushing Financial Corporation
Conference presentation Investor relations Beat · FinancialsLoop · Before After1 hit
24
The slide uses a dual-axis chart (bar for absolute dollars, line for percentage ratio) to illustrate the relationship between core expenses and asset efficiency.Flushing Financial | Results Presentation Deck | 40 slides · Flushing Financial Corporation
Conference presentation Investor relations Beat · Financials1 hit
25
Flushing Financial | Results Presentation Deck | 40 slidesFlushing Financial | Results Presentation Deck | 40 slides · Flushing Financial Corporation
Conference presentation Investor relations 1 hit
27
The slide uses a stacked bar chart to show deposit mix and a simple bar chart for noninterest bearing deposits, with a summary table for deposit costs at the bottom.Flushing Financial | Results Presentation Deck | 40 slides · Flushing Financial Corporation
Conference presentation Investor relations 1 hit
29
The chart is a donut chart showing portfolio composition by industry. The bottom footer notes an average loan size of $1.2MM.Flushing Financial | Results Presentation Deck | 40 slides · Flushing Financial Corporation
Conference presentation Investor relations 1 hit
05
Freightos | Results Presentation Deck | 23 slidesFreightos | Results Presentation Deck | 23 slides · Freightos
Conference presentation Investor relations 1 hit
13
Freightos | Results Presentation Deck | 23 slidesFreightos | Results Presentation Deck | 23 slides · Freightos
Conference presentation Investor relations 1 hit
09
Freyr | Results Presentation Deck | 13 slidesFreyr | Results Presentation Deck | 13 slides · FREYR
Conference presentation Investor relations Beat · Satisfaction1 hit
10
The slide presents a comparative financial table for Q4 and full-year 2022 vs 2023.Freyr | Results Presentation Deck | 13 slides · FREYR
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
The slide uses a waterfall chart to explain the change in cash position.Freyr | Results Presentation Deck | 13 slides · FREYR
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
08
Uses a pyramid/staircase diagram to show progression of clinical advantages.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
11
Data presented in a table format comparing patient cohorts against clinical metrics.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
12
Waterfall plot and spider plot showing patient-level clinical outcomes.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
15
The slide uses a bar chart to compare efficacy metrics (RECIST1.1, CA-125, PFS-6-month) across various clinical studies, with Genelux's VIRO-15 trial highlighted.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
16
The slide outlines a clinical trial protocol, specifically a randomized open-label study comparing an experimental arm to an active comparator arm.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
17
Includes Kaplan-Meier survival curves and patient cohort descriptions for two separate study groups.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
18
Includes specific patient case reports with RECIST criteria and biomarker data.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
21
The slide highlights the synergy between two existing therapies (TVI and Olvi-Vec) to create a new modality.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
23
The slide uses a combination of a bulleted list and a hub-and-spoke style visual representation of facility locations.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
24
The slide categorizes the platform's capabilities into therapeutic genes, immune modularity, and therapeutic antibodies.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
27
Includes specific footnotes regarding market close date, cash reporting date, and PIPE commitment details.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
28
The slide uses a dual-track visual: a list for past milestones and two curved arrows for future milestones.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
31
The slide lists key clinical advisors, highlighting their leadership roles in major oncology organizations and clinical trials.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
32
The slide uses two distinct chart types (spaghetti plot and waterfall plot) to validate the efficacy of the treatment.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
33
Includes a patient profile, a bar chart comparing PFS across treatment lines, and a longitudinal line chart tracking tumor size and CA-125 levels.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
34
Includes patient-specific histological evidence (Pt.#15A-01 and Pt.#15A-11) demonstrating the mechanism of action.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
36
The slide uses a combination of clinical timeline, patient history, and immunological data (ELISPOT) to correlate T-cell response with clinical outcome.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit